Pharma-Payer Partnerships in Emerging Markets 2017

Dublin, Nov. 09, 2017 -- The "Pharma-Payer Partnerships in Emerging Markets" report has been added to Research and Markets' offering.

This analysis covers self-pay markets, partially reimbursed, and reimbursed emerging markets. Pharmaceutical companies that can overcome payer resistance, and take a proactive approach, can reap significant rewards from innovative partnerships in challenging, high-growth markets.

Payer partnerships are becoming widespread as emerging markets become wealthier, but access challenges remain. Partnerships with proven success include strategic philanthropy, patient access programs, tiered pricing, and service support models. Many of the most successful strategies are hybrids of two or more pure partnership archetypes.

This analysis is a survey of recent industry experience with payer partnerships in emerging markets, using case studies and real-world exemplars to illustrate best practice. While there is no one size fits all approach to partnering in emerging markets, the author has considered in each case how best to address payer needs that cannot be served by the routine course of business.

Key Topics Covered:

1 EXECUTIVE SUMMARY

• Partnerships with payers facilitate access in emerging markets
• Partnerships with payers take many forms, depending on funding source
• Customization is key for successful partnerships in self-pay markets
• Even in reimbursed emerging markets, paying for outcomes is rare
• The most successful partnerships are driven at the local level

2 THE PHARMA-PAYER PARTNERSHIPS LANDSCAPE

• Payer partnerships are unlocking emerging-market opportunities
• The market structure shapes the partnership
• Bibliography

3 PARTNERSHIPS IN SELF-PAY EMERGING MARKETS

• Self-pay markets: summary of partnership options
• Donation partnerships
• Tiered pricing
• Continuous treatment programs
• Complementary health insurance
• Bibliography

4 PARTNERSHIPS IN REIMBURSED EMERGING MARKETS

• Service support can boost access in reimbursed markets
• Real-world evidence is gaining traction in emerging markets
• Risk sharing in reimbursed emerging markets
• Technology transfer in emerging markets
• Bibliography

5 CRITICAL SUCCESS FACTORS FOR PARTNERSHIPS IN EMERGING MARKETS

• Aligning partnerships with local goals and capabilities is key
• Assessing risk-reward in partnering options

6 APPENDIX

For more information about this report visit https://www.researchandmarkets.com/research/4r594n/pharmapayer

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Pharmaceuticals